đź“Ł ADDS 2027 Save the Date!

We hope you'll consider joining us for our 5th meeting, ADDS 2027, taking place Feb 8-10, 2027 at the Georgian Terrace Hotel in Atlanta, GA.

NOTE: Our office will be closed Friday, June 19th in observance of Juneteenth. We will reopen at regular business hours on Monday, June 22nd.

Subscribe to Receive Updates
Posts about

FDA guidance

digital biomarkers, digital endpoints, wearables, regulated clinical trials, FDA guidance, digital clinical outcome assessments

Navigating the FDA DHT Guidance: Perspectives from Across the Industry

Digital health technologies (DHT) can collect objective, multi-dimensional data passively and...
8 Minute Read
Read More
digital endpoints, fit-for-purpose, regulated clinical trials, DHT Operations, data quality, FDA guidance, AI

Planning Ahead: 5 Best Practices For The Integration of Wearables in Clinical Trials

Wearable, sensor-based digital health technologies (DHTs) can help biotech and pharma teams...
4 Minute Read
Read More
Data Science, Algorithm, regulated clinical trials, data quality, FDA guidance, AI

Demystifying AI: A Review of the Fundamentals and Applications in Drug Development

Artificial Intelligence (AI) has recently become a household term, with its influence permeating...
7 Minute Read
Read More
digital biomarkers, algorithms, Data Science, wearables, regulated clinical trials, DHT Operations, FDA guidance, digital clinical outcome assessments

Wearable DHT 101: Foundations for Use in Regulated Clinical Trials

Innovation is exciting, but it can also come with challenges; innovation in the life sciences...
4 Minute Read
Read More
clinical research, DHT, digital measure, wearables, patient centricity, clinical outcome assessment, FDA guidance, patient voice

A New Resource to Help Advance Patient-Focused Drug Development with DHTs

The need to transform the clinical trial process to deliver more effective treatments to patients...
5 Minute Read
Read More